Rohto Pharmaceutical Co.,Ltd. provides dividend guidance for the full year ending March 31, 2024. The company expects to pay JPY 15.00 against JPY 12.00 reported a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2,874 JPY | -0.55% | -8.65% | +1.09% |
Apr. 04 | Rohto Pharmaceutical Eyes MGO on Singapore's Eu Yan Sang International for 88 Billion Yen | MT |
Apr. 04 | Rohto Pharmaceutical, Mitsui & Co. to Acquire Singapore-Based Eu Yan Sang -- Update | DJ |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.09% | 4.25B | |
+32.23% | 694B | |
+29.39% | 593B | |
-1.59% | 371B | |
+19.98% | 331B | |
+7.21% | 290B | |
+14.25% | 239B | |
-3.03% | 209B | |
+10.02% | 209B | |
+8.68% | 169B |
- Stock Market
- Equities
- 4527 Stock
- News Rohto Pharmaceutical Co.,Ltd.
- Rohto Pharmaceutical Co.,Ltd. Provides Dividend Guidance for the Full Year Ending March 31, 2024